Evaluation of CSF Glial Fibrillary Acidic Protein (GFAP) as a Putative Marker for HIV-Associated Dementia

Author： Sporer B.   Missler U.   Magerkurth O.   Koedel U.   Wiesmann M.   Pfister H.  

Publisher： Springer Publishing Company

ISSN： 0300-8126

Source： Infection, Vol.32, Iss.1, 2004-02, pp. : 20-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Distribution of Glial Fibrillary Acidic Protein (GFAP) in the Intermediate Filaments of the Cultured Cells from a Patient with Tuberous Sclerosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 17, Iss. 7, 1990-07 ,pp. : 395-402

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 3, 2018-03 ,pp. : 477-483

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease

By  

ANNALS OF NEUROLOGY, Vol. 83, Iss. 1, 2018-01 ,pp. : 27-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Literature Review of the Feasibility of Glial Fibrillary Acidic Protein as a Biomarker for Stroke and Traumatic Brain Injury

By Schiff Leora  

Molecular Diagnosis & Therapy, Vol. 16, Iss. 2, 2012-04 ,pp. : 79-92

Adis International

Access to resources Recommend Favorite

Corticosteroids Reduce Glial Fibrillary Acidic Protein Expression in Response to Spinal Cord Injury in a Fetal Rat Model of Dysraphism

By  

Pediatric Neurosurgery, Vol. 45, Iss. 3, 2009-06 ,pp. : 198-204

Karger

Access to resources Recommend Favorite